As the April showers turn to May flowers, take a moment to check out some of the research ethics and oversight news that has been making headlines this month.
By Meryn Robinson, Educational Programs and Membership Services
While we’re already three weeks into the New Year, I hope that you’ll consider adding one more resolution to your list: keeping up with Research Ethics Roundup! This year, and always, we commit to sharing timely and relevant stories related to research ethics and oversight with our loyal readers. As you read along, please don’t hesitate to comment on the pieces that interest you. We would love to hear your thoughts!
by Avery Avrakotos, Education and Policy Manager, and Meryn Robinson, Educational Program and Membership Services
Technological advances, the growing need for comparative effectiveness research, an increasing demand for data transparency, and the continued globalization of the research enterprise were among some of the issues that human subjects protections professionals grappled with in 2013. For those involved in animal care and use, the year marked a continuation of efforts to educate the public about the value of animal research. As we reflect on 2013, and look ahead to what 2014 will bring, we are pleased to share with you a collection of Ampersand posts that reflect some of the year's major events, both for PRIM&R and [...] Read more
by Julie Fine, BS, Legal Specialist, Worldwide Research and Development, Pfizer Inc., La Jolla, California
While the 2013 Advancing Ethical Research (AER) Conference has drawn to a close, PRIM&R is pleased to continue sharing reflections from members of the PRIM&R Blog Squad to provide our readers with an inside peek of the conference.
[...] Read more
Research Ethics Roundup: The future of the CTSA program, sharing scientific data, and more
Tags:
by Maeve Luthin, JD, Professional Development Manager
Hopkins, UMD Await Word on Grant Funding Key in Medical Treatment Discoveries: In June, the Institute of Medicine (IOM) released a report detailing recommendations to the National Institutes of Health (NIH) regarding its administration of the Clinical and Translational Science Awards (CTSA) program, including that it should consolidate program leadership, establish clearer evaluation standards for applications, and encourage collaborating among participating institutions. CTSA decisions are expected in September. Now, institutions are waiting to see how the report will affect their funding.
<[...] Read more